Fundraising Fox

Bastiaan van der Baan

Investor

Venture Partner at XGEN Venture

Amsterdam, NL

About

Biotech executive with 20+ years focused on oncology and diagnostics, most recently Chief Clinical Officer of Agendia. Co-founder of ThromboDx, Qameleon Therapeutics and Oncosence. Joined XGEN in 2023.

Experience

  1. Scope Biosciences B.V.Chief Executive Officercurrent2026 — presentWageningen, Gelderland, Netherlands
  2. Lixte Biotechnology Holdings, Inc.Chief Technology Officercurrent2025 — present
  3. Lixte Biotechnology Holdings, Inc.Chief Executive Officer2023 — 2025Amsterdam, North Holland, Netherlands
  4. Lixte Biotechnology Holdings, Inc.Board Member2022 — 2025Pasadena, California, United States
  5. XGEN Venture SGR S.p.A.Venture Partnercurrent2023 — presentMilan, Lombardy, Italy
  6. Tethis S.p.ABoard Membercurrent2021 — presentMilan, Lombardy, Italy
  7. Agendia, Inc.Chief Clinical and BD Officer2012 — 2023Irvine California / Amsterdam The Netherlands
  8. Agendia, Inc.VP Marketing and Sales2008 — 2012Amsterdam, Netherlands / Irvine, CA
  9. Agendia, Inc.Director Business Development2004 — 2008The Randstad, Netherlands
  10. Qameleon TherapeuticsCo-Founder2015 — 2023The Randstad, Netherlands
  11. thromboDxCo-Founder2012 — 2016The Randstad, Netherlands
  12. Amsterdam Economic BoardBoard Member2009 — 2013The Randstad, Netherlands
  13. KreatechBusiness Development Manager2002 — 2003The Randstad, Netherlands
  14. Unilever │ICI│UnichemaSales Manager Mid Europe2000 — 2002Emmerich, Germany
  15. Unilever │ICI│UnichemaSales Manager Benelux Scandinavia1998 — 2000Gouda, Netherlands
  16. Unilever │ICI│UnichemaIndustrial Marketing Management Trainee1997 — 1998Kuala Lumpur, Malaysia / Gouda Netherlands

Education

  1. Wageningen University & ResearchMSc, Molecular Sciences1990 — 1996
  2. NIMA, Nederlands Instituut voor MarketingNIMA A & B1995
  3. Murmellius Gymnasium1984 — 1990

Skills & more

Regulatory ApprovalsMolecular DiagnosticsHealthcare ReimbursementPublic Equity OfferingsInvestor RelationsVenture CapitalNASDAQU.S. SEC FilingsBiotechnology25Lifesciences14Oncology17Business Development14
+12 moreCancerClinical TrialsPharmaceutical IndustryGenomicsStrategyMedical DevicesLife SciencesMolecular BiologyCommercializationProduct LaunchManagementGenetics

Languages Dutch · English · German

From Bastiaan's professional profile.

Same school

Shared employers

Colleagues at XGEN Venture